[Inhalation nitric oxide during heart transplantation]

Area of Science:

• Cardiology
• Pulmonary Hypertension
• Medical Devices

Background:

• Pulmonary hypertension is a critical complication in heart transplant recipients.
• Selective pulmonary vasodilation is essential for managing hemodynamics during and after cardiac surgery.

Purpose of the Study:

• To investigate the dose-dependent effects of inhaled nitric oxide (iNO) on central hemodynamics in heart transplant patients.
• To evaluate iNO's efficacy in assessing and treating pre-transplantation pulmonary hypertension and post-transplantation cardiac function.

Main Methods:

• Studied 24 patients undergoing heart transplantation.
• Administered inhaled nitric oxide (iNO) at varying concentrations (up to 40 ppm).
• Monitored central hemodynamic parameters, including pulmonary artery pressure, cardiac index, and ventricular function.

Main Results:

• iNO up to 20 ppm objectively assessed pulmonary hypertension reversibility.
• Doses >20 ppm iNO impaired left-ventricular function in specific patient subgroups.
• During left-ventricular bypass, iNO dose-dependently reduced pulmonary vascular resistance and improved cardiac output.
• Post-transplantation, 20 ppm iNO decreased pulmonary vascular resistance, stabilized cardiac function, and improved cardiac index and blood pressure.

Conclusions:

• Inhaled nitric oxide (iNO) is a valuable tool for managing pulmonary hypertension in heart transplantation.
• Careful dose titration of iNO is crucial to avoid adverse effects on left-ventricular function.
• iNO effectively improves hemodynamics and stabilizes transplanted heart function post-surgery.